|
17.03.2014 17:53:16
|
Cancer Genetics CFO Czerepak Resigns; Edward Sitar Named Successor
(RTTNews) - Cancer Genetics, Inc. (CGIX) said Monday that its Chief Financial Officer and Principal Accounting Officer Elizabeth Adkins Czerepak has resigned, effective March 31, to pursue other opportunities.
The company also said that it has appointed Edward Sitar as Chief Financial Officer, effective April 1.
Sitar was most recently the Chief Financial Officer of Healthagen, a subsidiary of Aetna Co. Prior to that, he was the Executive VP and Chief Financial Officer of ActiveHealth Management, also a subsidiary of Aetna.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cancer Genetics Incmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Cancer Genetics Incmehr Analysen
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.